Search Results - "Serre, Raphael"

Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies by Barbolosi, Dominique, Crona, Joakim, Serre, Raphaël, Pacak, Karel, Taieb, David

“…Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL)…”
Get full text

Mathematical modeling of peripheral blood neutrophil kinetics to predict CLAD after lung transplantation by Coiffard, Benjamin, Reynaud-Gaubert, Martine, Rey, Jean-Baptiste, Cousin, Elissa, Grosdidier, Charlotte, Nicolino-Brunet, Corinne, Dignat-George, Françoise, Papazian, Laurent, Thomas, Pascal Alexandre, Barbolosi, Dominique, Serre, Raphaël

“…The presence of neutrophils in the lung was identified as a factor associated with CLAD but requires invasive samples. The aim of this study was to assess the…”
Get full text

Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients by Barlesi, Fabrice, Imbs, Diane-Charlotte, Tomasini, Pascale, Greillier, Laurent, Galloux, Melissa, Testot-Ferry, Albane, Garcia, Mélanie, Elharrar, Xavier, Pelletier, Annick, André, Nicolas, Mascaux, Céline, Lacarelle, Bruno, Cheikh, Raouf El, Serre, Raphaël, Ciccolini, Joseph, Barbolosi, Dominique

“…Using mathematical modelling allows to select a treatment's regimen across infinite possibilities. Here, we report the phase I assessment of a new schedule for…”
Get full text

Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine by Barbolosi, Dominique, Summer, Ilyssa, Meille, Christophe, Serre, Raphaël, Kelly, Antony, Zerdoud, Slimane, Bournaud, Claire, Schvartz, Claire, Toubeau, Michel, Toubert, Marie-Elisabeth, Keller, Isabelle, Taïeb, David

“…Radioiodine therapy (RAI) has traditionally been used as treatment for metastatic thyroid cancer, based on its ability to concentrate iodine. Propositions to…”
Get full text

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol by le Guevelou, Jennifer, Debaigt, Colin, Saada-Bouzid, Esma, Viotti, Julien, Khalladi, Nazim, Thibouw, David, Penel, Nicolas, Sunyach, Marie Pierre, Moureau-Zabotto, Laurence, Benchalal, Mohamed, Veresezan, Ovidiu, Ducassou, Anne, le Pechoux, Cecile, Jolnerovski, Maria, Bazille, Celine, Vaur, Dominique, Escande, Alexandre, Serre, Raphael, Lovera, Christine, Thariat, Juliette

“…IntroductionUp to 50% of soft tissue sarcoma (STS) patients develop metastases in the course of their disease. Cytotoxic therapy is a standard treatment in…”
Get full text

Abstract 4542: A mathematical model for immuno-chemotherapy by Serre, Raphael, Barbolosi, Dominique

“…Abstract Chemotherapy and immunotherapy have sometimes been considered two mutually exclusive approaches. On the one hand, chemotherapy has long been…”
Get full text

Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy by Serre, Raphael, Benzekry, Sebastien, Padovani, Laetitia, Meille, Christophe, André, Nicolas, Ciccolini, Joseph, Barlesi, Fabrice, Muracciole, Xavier, Barbolosi, Dominique

“…Combining radiotherapy with immune checkpoint blockade may offer considerable therapeutic impact if the immunosuppressive nature of the tumor microenvironment…”
Get full text

Abstract 2704: Radiotherapy and immunotherapy in cancer: A mathematical model by Serre, Raphael, Muracciole, Xavier, Ciccolini, Joseph, Benzekry, Sebastien, Barbolosi, Dominique

“…Abstract The rise of immunotherapy is a major breakthrough in oncology. Recently, the combination of radiotherapy with the blockade of immune checkpoint…”
Get full text

Optimization of trabectedin temporal protocol using mathematical PK/PD modeling by Andriantsoa, Maeva, El Cheikh, Raouf, Imbs, Diane Charlotte, Serre, Raphael, Duffaud, Florence, Ciccolini, Joseph, Barbolosi, Dominique, Salas, Sébastien

“…Abstract only…”
Get full text

Model-driven metronomic vinorelbine in heavily pre-treated metastatic NSCLC and PM patients: Results of a phase I/II study by Ciccolini, Joseph, Cousin, Elissa, Deyme, Laure, Imbs, Diane-Charlotte, Bonnet, Sylvanie, Serre, Raphael, Barbolosi, Matthieu, Greiller, Laurent, Tomasini, Pascale, Galloux, Melissa, Lacarelle, Bruno, Barbolosi, Dominique, Barlesi, Fabrice

“…Abstract only e20505 Background: A phase I/II trial (NCT02555007) of oral metronomic Vinorelbine derived from a mathematical model was performed in heavily…”
Get full text

Immunologically effective dose: a practical model for immuno-radiotherapy by Serre, Raphaël, Barlesi, Fabrice, Muracciole, Xavier, Barbolosi, Dominique

“…Concomitant radiotherapy with immune checkpoint blockade could be synergistic. Out-of-field effects could improve survival by slowing or blocking metastatic…”
Get full text

Abstract 4062: A computational driven protocol of metronomic oral vinorelbine in metastatic non small cell lung cancer by Imbs, Diane-Charlotte, Cheikh, Raouf El, Ciccolini, Joseph, Serre, Raphaël, Barlesi, Fabrice, Barbolosi, Dominique

“…Abstract Over the last decade, metronomic chemotherapy (MC) has emerged as an alternative way to administrate chemotherapy. MC can be defined as regular…”
Get full text